Optimizing Treatment in Patients with ROS1 Rearranged NSCLC
Annenberg Center for Health Sciences
About Optimizing Treatment in Patients with ROS1 Rearranged NSCLC
Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.
- Publisher
- Annenberg Center for Health Sciences
- Category
- health & fitness
- Language
- en
- Explicit
- No
- First episode
- 7 Oct 2024
- Latest episode
- 7 Oct 2024
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.